SLC6A4 and pulmonary arterial hypertension: They pointed out that the identification of SERT/serotonin pathway defects could also guide new therapeutic strategies targeting their functions in infants with pulmonary hypertension and its lethal form—alveolar capillary dysplasia with pulmonary vein malposition.